Related Experiment Video
Updated: May 28, 2026

Left Atrial Ligation in the Avian Embryo as a Model for Altered Hemodynamic Loading During Early Vascular Development
Published on: June 16, 2023
Is There a Unified Etiology of Hypoplastic Left Heart Syndrome? Evaluating Genetic, Structural, and Hemodynamic
Reese Leonhard1,2, Zachary Beau Phillips1,2, Jamie Wilson1
1Congenital Heart Center, Departments of Surgery and Pediatrics, UF Health Shands Hospital, University of Florida, 1600 SW Archer Rd, Gainesville, FL 32608, USA.
Insights
Hypoplastic left heart syndrome (HLHS) likely results from complex interactions between genetic susceptibility, altered blood flow, and in utero environmental factors. Different underlying causes and timing of insults explain the varied HLHS phenotypes.
Area of Science:
- Cardiovascular Medicine
- Developmental Biology
- Genetics
Background:
- Hypoplastic left heart syndrome (HLHS) is a severe congenital heart defect characterized by underdevelopment of the left heart structures.
- HLHS is typically lethal in neonates without intervention, and its etiology remains incompletely understood, with no single theory explaining its phenotypic variability.
- Existing theories fail to fully elucidate the precipitating events leading to HLHS development.
Purpose of the Study:
- To critically evaluate leading theories on HLHS pathogenesis, including hemodynamic disturbances, primary myocardial defects, valvar malformations, and genetic/epigenetic factors.
- To propose a novel, data-driven framework for understanding HLHS pathogenesis and its subtypes.
- To identify potential unifying explanations for HLHS etiology by examining cardiac progenitor cell dysregulation.
Main Methods:
- Review of human fetal imaging, histopathology, genetic studies, and animal models.
- Critical analysis of findings as potential causal factors for HLHS patterns and phenotypes.
- Evaluation of strengths and weaknesses of existing theoretical models (flow theory, myocardial/valve-first models, genetic studies, multifactorial framework).
Main Results:
- The flow theory is supported by animal models but doesn't explain initial causes or histological features.
- Myocardial and valve-first models lack strong experimental bases for mediating HLHS.
- Genetic studies identify candidate mutations but show incomplete penetrance; a multifactorial framework integrates mechanisms but lacks research pathways.
Conclusions:
- No single hypothesis fully explains HLHS initiation, progression, or clinical presentation.
- HLHS spectrum reflects a complex interplay of genetic susceptibility, flow-dependent remodeling, and in utero environmental factors.
- A multifactorial model offers the most coherent explanation for HLHS heterogeneity, with timing of insult critical for determining subtype.
Abstract:
Background: Hypoplastic left heart syndrome (HLHS) is defined as "a spectrum of congenital cardiovascular malformations with normally aligned great arteries without a common atrioventricular junction, characterized by underdevelopment of the left heart with significant hypoplasia of the left ventricle including atresia, stenosis, or hypoplasia of the aortic or mitral valve, or both valves, and hypoplasia of the ascending aorta and aortic arch". Without treatment, HLHS is usually lethal in the neonate. Many hypotheses have been advanced to explain the etiology of HLHS; however, no single theory appears to fully explain the phenotypic variability seen in HLHS. Furthermore, many of these theories offer no explanations regarding the precipitating events which lead to the development of HLHS. Objective: This review considers and critically evaluates the strengths and weaknesses of the leading theories proposed to explain the pathogenesis of HLHS-including hemodynamic disturbances, primary myocardial structural defects, valvar malformations, and genetic or epigenetic alterations that may provoke developmental and anatomic abnormalities. After presenting each model, we propose a novel, comprehensive, and data-driven framework which may assist researchers in developing models for the pathogenesis of the various subtypes of HLHS. Methods: Key findings from human fetal imaging, histopathology, genetic studies, and animal models were considered, as well as the hypothetical contribution of each in observed HLHS phenotypes. The rationales for these findings as causal factors initiating individual HLHS patterns, as well as how they might contribute to HLHS in general, were critically analyzed. Results: The flow theory is strongly supported by animal models and in utero interventions that demonstrate the impact of altered hemodynamics on cardiac morphogenesis. However, the flow theory fails to identify initial causes of disturbed flow or related histological features of HLHS like endocardial fibroelastosis. The myocardial and valve-first models suggest an important role in developmental defects, but do not necessarily have a strong experimental basis that provides explanations for how they mediate HLHS. Genetic studies in patients with HLHS have identified several candidate causal mutations. However, such genetic causes of HLHS exhibit incomplete phenotypic penetrance and clinical impact. A multifactorial framework attempts to integrate these diverse mechanisms and may provide the most coherent explanation that can accommodate the heterogeneity and variable presentation of HLHS. Such a framework may identify multiple forces that drive disease but does not provide useful pathways for future research about HLHS. Conclusions: No single hypothesis has fully explained how HLHS is initiated, progresses, and presents with the clinical conditions that are encountered by cardiac surgeons and cardiologists. The most current models suggest that the spectrum of HLHS reflects acomplex interaction between genetic susceptibility, flow-dependent cardiac remodeling, and environmental factors in utero. A multifactorial model integrates these diverse mechanisms and may provide the most coherent explanation for the various phenotypic variations in HLHS. Based on our analysis of the most current data and the strengths and weaknesses of the current theoretical frameworks, we propose a novel research strategy aimed at identifying specific cardiac progenitor cell populations whose dysregulation may represent a unifying explanation for the etiology of the various phenotypes of HLHS. Based on the arguments made throughout this manuscript that evaluate the various genetic, structural, and hemodynamic models of initiation of disease, we believe that the significant phenotypic variability across the spectrum of HLHS (i.e., the different anatomic subtypes for "classic" HLHS) most likely reflects different underlying etiologies and mechanisms. At the very least, it is very likely that the timing of the insult is critical in determining anatomic subtype. Based on the published data and the arguments within this manuscript, it seems naive to think that there is a single unifying mechanism explain all forms of HLHLS.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Pathophysiology of Heart Failure
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Heart Failure II: Pathophysiology
Mitral Stenosis I: Introduction
Heart Failure I: Introduction

